Background: Memory can be deleteriously affected by cancer treatment. It is important to quantify these effects, to assess the effectiveness of interventions to ameliorate them, and to monitor changes in cancer patients' memories over time. However, brief and reliable screening measures of cancer treatment-related memory problems are lacking. We report on the latent structure and reliability analysis of a brief patient self-reported cancer-related memory problem screening measure (SRMP).
Methods: Participants (N=781) included in this analysis were part of a larger study on cancer-related fatigue. Patients completed the Fatigue Symptom Checklist (FSCL) at four time points. Five items from the FSCL that assess memory problems were aggregated into the SRMP. Suitability of the data for latent structure analysis was determined using the various criteria: Kaiser-Myer-Olkin, Bartlett's Test of sphericity, Kaiser's simplest criterion test of eigenvalue (λ) >1, and the presence of item-correlation coefficients of r ≥ 0.30. Principal components analysis (PCA) and Cronbach coefficient alphas (α) were calculated to determined validity and internal consistency of the SRMP.
Results: Reliability assessment of the SRMP revealed high internal consistency of the SRMP as indicated by α = 0.90. The PCA revealed a one-dimensional measure with a single component with λ > 1 that explained 71% of the variance. The KMO value was .87, and the Bartlett's Test of Sphericity was significant (p < 0.001). Subsequent reliability assessments of the SRMP revealed α of 0.90 and above, all with one component explaining 71% to 73% of the variances.
Conclusion: The results support the use of the SRMP as a one-dimensional brief screening measure of cancer treatment-related memory problems. The SRMP could be used as an initial indicator of underlying memory problems that may need further examination. Future studies need to establish the construct validity of the SRMP.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313570 | PMC |
Alzheimers Res Ther
January 2025
Radiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Background: The imbalance of glutamate (Glu) and gamma-aminobutyric acid (GABA) neurotransmitter system plays a crucial role in the pathogenesis of Alzheimer's disease (AD). Riluzole is a Glu modulator originally approved for amyotrophic lateral sclerosis that has shown potential neuroprotective effects in various neurodegenerative disorders. However, whether riluzole can improve Glu and GABA homeostasis in AD brain and its related mechanism of action remain unknown.
View Article and Find Full Text PDFInt J Behav Nutr Phys Act
January 2025
Department of Sports Science and Physical Education, The Chinese University of Hong Kong, Hong Kong SAR, China.
Background: Physical activity (PA) interventions have been shown to yield positive effects on cognitive functions. However, it is unclear which type of PA intervention is the most effective in children and adolescents with Neurodevelopmental Disorders (NDDs). This study aimed to compare the effectiveness of different types of PA interventions on cognitive functions in children and adolescents with NDDs, with additional analyses examining intervention effects across specific NDD types including attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
View Article and Find Full Text PDFBMC Med Educ
January 2025
Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Background: Sleep is an active process that affects human health and quality of life. Sleep is essential for learning and memory consolidation. Good sleep is required for good academic performance.
View Article and Find Full Text PDFBMC Med Imaging
January 2025
Department of Physiology, Faculty of Medicine, AJA University of Medical Science, Tehran, Iran.
Background: Cognitive networks impairments are common in neuropsychiatric disorders like Attention Deficit Hyperactivity Disorder (ADHD), bipolar disorder (BD), and schizophrenia (SZ). While previous research has focused on specific brain regions, the role of the procedural memory as a type of long-term memory to examine cognitive networks impairments in these disorders remains unclear. This study investigates alterations in resting-state functional connectivity (rs-FC) within the procedural memory network to explore brain function associated with cognitive networks in patients with these disorders.
View Article and Find Full Text PDFBiol Psychiatry Cogn Neurosci Neuroimaging
January 2025
Department of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Background: Effective connectivity (EC) analysis provides valuable insights into the directionality of neural interactions, crucial for understanding the mechanisms underlying cognitive and emotional regulation in depressive and anxiety disorders. This study examined EC within key neural networks during working memory (WM) and emotional regulation (ER) tasks in young adults, both healthy and seeking help from mental health professionals for emotional distress.
Methods: Dynamic Causal Modeling (DCM) was employed to analyze EC in two independent samples (n=97 and n=94).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!